---
title: "C&D INTL GROUP: Xu Xiaoxi appointed as a non-executive director"
description: "According to the announcement from C&D INTL GROUP, the board of directors received a written resignation from Mr. Huang Wenzhou, who is resigning as a non-executive director due to retirement, effecti"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/240042708.md"
published_at: "2025-05-13T14:55:02.000Z"
---

# C&D INTL GROUP: Xu Xiaoxi appointed as a non-executive director

> According to the announcement from C&D INTL GROUP, the board of directors received a written resignation from Mr. Huang Wenzhou, who is resigning as a non-executive director due to retirement, effective May 13, 2025. The board has also received a written resignation from Mr. Zheng Yongda, who is resigning as a non-executive director due to changes in work arrangements, effective May 13, 2025. Ms. Xu Xiaoxi has been appointed as a non-executive director, effective May 13, 2025

According to the announcement from C&D INTL GROUP (01908), the board of directors received a written resignation from Mr. Huang Wenzhou, who is resigning as a non-executive director due to retirement, effective May 13, 2025. The board has also received a written resignation from Mr. Zheng Yongda, who is resigning as a non-executive director due to changes in work arrangements, effective May 13, 2025.

Xu Xiaoxi has been appointed as a non-executive director, effective May 13, 2025

### Related Stocks

- [01908.HK - C&D INTL GROUP](https://longbridge.com/en/quote/01908.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Standard Chartered PLC (OTCMKTS:SCBFF) Sees Significant Growth in Short Interest | Standard Chartered PLC (OTCMKTS:SCBFF) experienced a significant increase in short interest, rising 21.1% to 210,583 sha | [Link](https://longbridge.com/en/news/276119010.md) |
| CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | [Link](https://longbridge.com/en/news/276051793.md) |
| CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | [Link](https://longbridge.com/en/news/276035104.md) |
| Will China Literature Turn The Page? | China Literature Ltd. expects a net loss of up to 850 million yuan for last year, primarily due to a 1.8 billion yuan go | [Link](https://longbridge.com/en/news/276113491.md) |
| Aequs Entered Into MoU With Government Of Tamil Nadu For Setting Up Manufacturing Unit | Aequs Ltd :AEQUS LTD - ENTERED INTO NON- BINDING MEMORANDUM OF UNDERSTANDING WITH GUIDANCEAEQUS- ENTERS MOU WITH GOVERNM | [Link](https://longbridge.com/en/news/276049940.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
